Evidence map›Paper›PMID 25540383›Full record

ArticleJournal of virology2015

Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.

Elizabeth A White, Rebecca E Kramer, Justin H Hwang, Arun T Pores Fernando, Nana Naetar, William C Hahn, Thomas M Roberts, Brian S Schaffhausen, David M Livingston, Peter M Howley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Papillomaviruses: a systematic review.Genetics and molecular biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elizabeth A WhiteDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Rebecca E KramerDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Justin H HwangDepartment of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Arun T Pores FernandoDepartments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Nana NaetarDepartments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
William C HahnDepartments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Thomas M RobertsDepartments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Brian S SchaffhausenDepartment of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
David M LivingstonDepartments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Peter M HowleyDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA peter_howley@hms.harvard.edu.
Harvard University · USTufts University · USDana-Farber Cancer Institute · US

Funding

VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAYP01CA050661 · NCI · DANA-FARBER CANCER INSTITUTE · PI LIVINGSTON, DAVID MORSE · 1989 to 2013
$35.8M
Analysis of Cellular Events that Allow Papillomavirus ReplicationF32AI080075 · NIAID · HARVARD MEDICAL SCHOOL · PI WHITE, ELIZABETH A · 2008 to 2010
$149k
NCI NIH HHS P01 CA050661NCI NIH HHS P01CA050661NIAID NIH HHS F32 AI080075NIAID NIH HHS F32AI080075
6 · The paper itself

Abstract

unlabelledMany of the small DNA tumor viruses encode transforming proteins that function by targeting critical cellular pathways involved in cell proliferation and survival. In this study, we have examined whether some of the functions of the polyomavirus small T antigens (ST) are shared by the E6 and E7 oncoproteins of two oncogenic papillomaviruses. Using three different assays, we have found that E7 can provide some simian virus 40 (SV40) or murine polyomavirus (PyV) ST functions. Both human papillomavirus 16 (HPV16) and bovine papillomavirus (BPV1) E7 proteins are capable of partially substituting for SV40 ST in a transformation assay that also includes SV40 large T antigen, the catalytic subunit of cellular telomerase, and oncogenic Ras. Like SV40 ST, HPV16 E7 has the ability to override a quiescence block induced by mitogen deprivation. Like PyV ST, it also has the ability to inhibit myoblast differentiation. At least two of these activities are dependent upon the interaction of HPV16 E7 with retinoblastoma protein family members. For small T antigens, interaction with PP2A is needed for each of these functions. Even though there is no strong evidence that E6 or E7 share the ability of small T to interact with PP2A, E7 provides these functions related to cellular transformation. IMPORTANCE: DNA tumor viruses have provided major insights into how cancers develop. Some viruses, like the human papillomaviruses, can cause cancer directly. Both the papillomaviruses and the polyomaviruses have served as tools for understanding pathways that are often perturbed in cancer. Here, we have compared the functions of transforming proteins from several DNA tumor viruses, including two papillomaviruses and two polyomaviruses. We tested the papillomavirus E6 and E7 oncoproteins in three functional assays and found that E7 can provide some or all of the functions of the SV40 small T antigen, another well-characterized oncoprotein, in two of these assays. In a third assay, papillomavirus E7 has the same effect as the murine polyomavirus small T protein. In summary, we report several new functions for the papillomavirus E7 proteins, which will contribute new insights into the roles of viruses in cancer and the cellular pathways they perturb in carcinogenesis.

Indexed as

Cell Transformation, ViralAntigens, Polyomavirus TransformingGenetic Complementation TestHuman papillomavirus 16HumansOncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor ProteinsSimian virus 40Antigens, Polyomavirus TransformingE6 protein, Human papillomavirus type 16oncogene protein E7, Bovine papillomavirus type 1oncogene protein E7, Human papillomavirus type 16Oncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor Proteins

Identifiers

PMID25540383
PMCPMC4325735
OpenAlexW2021800860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.